DEF 14A

Company

Entera Bio Ltd.

Filed

July 29, 2022

Period of Report

July 29, 2022

Accession Number

0001178913-22-002838

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →